Status:
UNKNOWN
Development and Validation of an Artificial Intelligence-assisted Strategy Selection System for Colonoscopy Cleaning
Lead Sponsor:
Renmin Hospital of Wuhan University
Conditions:
Colorectal Adenoma
Eligibility:
All Genders
18+ years
Brief Summary
Patients with poor inadequate bowel preparation need to undergo secondary colonoscopy. but the evaluation of intestinal cleanliness is judged by doctors subjectively. there are no objective and effect...
Detailed Description
Colorectal disease as a common human disease seriously affects the health of human life. With the aging of the population, the change of diet structure and the aggravation of environmental pollution, ...
Eligibility Criteria
Inclusion
- Male or female aged 18 or above;
- Colonoscopy is needed to further clarify the characteristics of digestive tract diseases;
- Patients able to give informed consent were eligible to participate.
- Able and willing to comply with all study process.
- No intestinal organic disease.
Exclusion
- Has participated in other clinical trials, signed informed consent and was in the follow-up period of other clinical trials.
- Has participated in clinical trials of the drug and is in the elution period of the experimental drug or control drug.
- Drug or alcohol abuse or psychological disorder in the last 5 years.
- Patients in pregnancy or lactation.
- Known polyposis syndromes.
- Gastrointestinal Bleeding.
- A history of inflammatory bowel disease, colorectal cancer and colorectal surgery.
- A history of colorectal surgery.
- Patients with a contraindication for biopsy.
- Previous history of allergy to ingredient of bowel cleanser.
- Patients with intestinal obstruction or perforation, toxic megacolon, Colectomy, heart failure (Grade III or IV) , severe cardiovascular disease, severe liver failure or renal insufficiency, etc. .
- Researchers believe that the patient is not suitable to participate in the trial.
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 16 2020
Estimated Enrollment :
657 Patients enrolled
Trial Details
Trial ID
NCT04444908
Start Date
May 11 2020
End Date
November 16 2020
Last Update
November 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renmin hospital
Wuhan, Hubei, China, 430000